drug · oligonucleotide
patient view →olezarsen sodium
Marketedupdated 2mo agoby $IONS IONIS PHARMACEUTICALS INC🔗 ChEMBL
Approvedcommunity read0 votes
Oligonucleotide drug with a maximum clinical stage of Unknown (across all indications), with 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that